|
Novel Glyco-tests to Predict Chemoresistance
|
3R43CA213766-01A1S2
|
$149,785
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
The Madrina Network Web Portal
|
3R44CA177037-03S1
|
$34,313
|
MATIELLA, ANA
|
ACMA SOCIAL MARKETING
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S3
|
$3,000
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
Oral formulation for novel inhibitor of Ras driven cancers
|
3R43CA217502-01A1S1
|
$2,000
|
CANZONERI, JOSHUA
|
ADT PHARMACEUTICALS, LLC
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
4R44CA224460-02
|
$1,111,364
|
DAUNCH, WILLIAM
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation
|
4R44CA203336-02
|
$659,516
|
AGUILAR-CORDOVA, ESTUARDO
|
ADVANTAGENE, INC
|
|
Novel Strategies for Precision T-cell Therapies
|
3R01CA198095-03S1
|
$107,431
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Synergistic co-targeting of pro-apoptotic BAX and anti-apoptotic BCL-XL in cancer
|
1F31CA236434-01
|
$44,524
|
LOPEZ-ARROYO, ANDREA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Ca2+/CaM-Dependent Protein Kinase II: A Novel Target in Osteosarcoma
|
1R43CA159562-01A1
|
$279,182
|
Schulman, Howard
|
ALLOSTEROS THERAPEUTICS, INC.
|
|
Novel IL-15 Superagonist Therapy for Bladder Cancer
|
6R44CA156740-05
|
$999,919
|
RHODE, PETER
|
ALTOR BIOSCIENCE. LLC
|
|
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues
|
1R43CA236097-01
|
$300,000
|
LIM, MARK
|
AMBERGEN, INC
|
|
11th AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
|
1R13CA236113-01
|
$74,000
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S1
|
$2,000
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S2
|
$126,060
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
3U24CA180803-05S1
|
$335,460
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Development of transporter targeted platinum drugs for neuroblastoma
|
1R43CA174132-01
|
$172,738
|
Mamelok, Richard
|
APRICITY THERAPEUTICS, INC.
|
|
Integrative Oncology: From Research to Practical Applications
|
1R13CA236121-01
|
$5,000
|
RAO, SANTOSH
|
BANNER HEALTH
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying B
|
5R01CA154489-02
|
$326,398
|
ALLEN, CARL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies
|
3U19CA203654-02S1
|
$147,830
|
AMOS, CHRISTOPHER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer-associated fibroblast in the regulation of bladder cancer stem cells
|
3R01CA175397-05S1
|
$110,950
|
CHAN, KEITH SYSON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving T-cell therapies for neuroblastoma
|
5R01CA142636-03
|
$377,399
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
5R01CA137019-03
|
$291,218
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk
|
1K23CA158148-01A1
|
$169,983
|
Gramatges, Maria
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
2P50CA126752-06
|
$2,300,000
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of
|
5K07CA157923-02
|
$148,700
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and Targeting Onocgenic MYC Enhancer Control in Pediatric Tumors
|
3R01CA215452-02S2
|
$45,800
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Localization and Function of NKT Cells in Neuroblastoma
|
5R01CA116548-07
|
$234,457
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genomic Approaches to Defining Inherited Basis of Childhood Cancer
|
5R01CA138836-03
|
$433,740
|
PLON, SHARON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Clinical Research Training Program
|
2K12CA090433-11
|
$742,728
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
5R01CA132899-04
|
$335,446
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
5R01CA131027-05
|
$308,958
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Training Program in Pediatric Cancer Epidemiology and Control
|
5R25CA160078-02
|
$387,302
|
SPITZ, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Combating Subclonal Evolution of Resistant Cancer Phenotypes
|
3U54CA209978-03S1
|
$125,000
|
BILD, ANDREA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Human natural killer cells: Advancing biology and clinical applications
|
7R35CA210087-02
|
$992,214
|
CALIGIURI, MICHAEL
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
4UH3CA213385-03
|
$87,498
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Multifunctional immunoPET tracers for pancreatic and prostate cancer
|
7R01CA174294-06
|
$377,890
|
WU, ANNA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cytology-Free POC Cervical Cancer Diagnostics for Global Health
|
4UH3CA202663-03
|
$344,918
|
WEIDEMAIER, KRISTIN
|
BECTON, DICKINSON AND COMPANY
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-09
|
$2,300,000
|
McDermott, David
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Dissecting sarcoma complexity via innovative microRNA and informatics approaches
|
5K22CA138716-03
|
$191,160
|
Spentzos, Dimitrios
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Parallel and high throughput isolation of cfDNA to target detection of rare, highly conserved nucleotide polymorphisms
|
1R43CA228923-01A1
|
$286,548
|
MULLER, ROLF
|
BIOFLUIDICA, INC
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
3R01CA079830-11S1
|
$22,311
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-11
|
$320,196
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
4R00CA134743-03
|
$233,147
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|